ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CSTL Castle Biosciences Inc

24.24
0.02 (0.08%)
After Hours
Last Updated: 17:30:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 246,374
Bid Price 23.10
Ask Price 25.14
News -
Day High 24.935

Low
9.2601

52 Week Range

High
26.70

Day Low 24.18
Company Name Stock Ticker Symbol Market Type
Castle Biosciences Inc CSTL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.08% 24.24 17:30:00
Open Price Low Price High Price Close Price Prev Close
24.38 24.18 24.935 24.24 24.22
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,526 246,374 $ 24.41 $ 6,013,355 - 9.2601 - 26.70
Last Trade Time Type Quantity Stock Price Currency
18:30:59 5 $ 24.72 USD

Castle Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
666.21M 27.45M - 219.79M -57.47M -2.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Castle Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CSTL Message Board. Create One! See More Posts on CSTL Message Board See More Message Board Posts

Historical CSTL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.5125.1023.7824.20264,956-0.27-1.10%
1 Month19.0425.9118.7623.05273,3035.2027.31%
3 Months24.3125.9117.4221.62255,863-0.07-0.29%
6 Months19.5025.9117.4221.52240,2444.7424.31%
1 Year22.7326.709.260118.00394,7681.516.64%
3 Years55.0778.929.260128.11280,156-30.83-55.98%
5 Years20.00107.699.260134.47252,2704.2421.20%

Castle Biosciences Description

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Your Recent History

Delayed Upgrade Clock